Norry Elliot (CIK 0001798117)

Latest company ownership

ADAP - Adaptimmune Therapeutics PLC

Role: Chief Medical Officer

Shares held

7,510

Last filed at

Jan 17, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jan 17, 2025	Jan 17, 2025	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-5,584	-42.65%	✗	$3.2K
Jan 13, 2025	Jan 15, 2025	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-22,195	-41.63%	✗	$12.9K
Jan 16, 2024	Jan 17, 2024	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-20,563	-40.34%	✗	$14.1K
Jan 11, 2024	Jan 12, 2024	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-11,808	-39.69%	✗	$10K
Jan 17, 2023	Jan 17, 2023	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-2,159	-38.21%	✗	$4K
Jan 11, 2023	Jan 12, 2023	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-11,292	-37.95%	✗	$19.4K
Jan 4, 2023	Jan 4, 2023	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-876	-39.16%	✗	$1.5K
Jan 18, 2022	Jan 18, 2022	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-2,121	-37.54%	✗	$6.8K
Jan 11, 2022	Jan 13, 2022	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-4,624	-37.44%	✗	$16.4K
Jan 4, 2022	Jan 5, 2022	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-849	-37.95%	✗	$3.5K
Jan 19, 2021	Jan 19, 2021	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	46.3	-2,111	-37.36%	✗	$12K
Jan 12, 2021	Jan 12, 2021	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-841	-37.59%	✗	$5.2K
Jan 4, 2021	Jan 5, 2021	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-845	-37.77%	✗	$4.5K
Jan 14, 2020	Jan 15, 2020	Adaptimmune Therapeutics PLC	Chief Medical Officer	Sell	47.5	-911	-40.72%	✗	$4.7K